Mention of the 'household name' ambition in link below about Dusseldorf meeting from last week - 1st Jan 2026 is the date I heard on the Nasdaq interview last year regarding household name. We know a tanning product is the holy grail long imagined by many of us, and I guess that the only way they could achieve that is with a Botox or Ozempic type of product appeal which safe, protective and sunless tanning would certainly be. Let's see what happens, none of this is priced-in in the slightest so it's sort of like holding a lottery ticket on top of your investment in a very profitable company running a Phase 3 into a blockbuster as well as starting a share buyback.
https://www.finanznachrichten.de/nachrichten-2024-03/61813107-clinuvel-pharmaceuticals-limited-photomedicine-pioneer-clinuvel-unveils-clinical-cosmetic-ambitions-to-german-investors-399.htm
All IMO DYOR
Food for Thought, page-32
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.74 |
Change
-0.240(1.60%) |
Mkt cap ! $738.1M | |||
| Open | High | Low | Value | Volume |
| $14.99 | $15.02 | $14.61 | $887.1K | 59.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 88 | $14.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.74 | 6 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |